The Hypercoagulability in Mercury Chloride Intoxicated Dogs

Summary

Experimental acute mercury chloride intoxication has been produced in the dog by subcutaneous injection of HgCl₂ in a daily dose of 3 mg/kg of weight for 3 days. The following features of hypercoagulability of dog blood have been found: increase of fibrinogen level, increase of factors II and VII, shortening of the thrombin and prothrombin times, shortening of the thromboelastographic “r” and “k” values, increase of “ma” and “me” values, increase of platelet adhesiveness. On the other hand plastic clotting time was slightly prolonged.

It has been postulated that hypercoagulability in the dog during mercury chloride intoxication is caused by the increase of inactive clotting factors. This may be connected with disturbances in the plasma protein balance in nephrosis.

• References

• 1 Astrup T, Müllertz S. The fibrin plate method for estimation fibrinolytic activity. Arch. Biochem. 1952; 40: 346
• 2 Barkhan P, Lai M, Stevenson M. Antihaemophilic factor (factor VIII) and alpha₂-globulin. Brit. J. Haemat. 1963; 9: 499
• 3 Botti R.E, Ratnoff O.D. Studies on the pathogenesis of thrombosis: an experimental “hypercoagulable” state induced by the intravenous injection of ellagic acid. J. Lab. clin. Med. 1964; 64: 385
• 4 Burstein M, Samaille J. Nouvelle methode de separation et de dosage des lipoproteines de faible densite. Ann. Biol. Clin. 1959; 17: 23
• 5 Caen J. Is fibrinogen the plasma co-factor in ADP induced human platelet aggregation?. Nature (Paris) 1965; 205: 1120
• 6 Cross M.J. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 12: 524
• 7 Egeberg O. Blood coagulation in renal failure. Scand. J. clin. Lab. Invest. 1962; 14: 163
• 8 Galasiński W, Worowski K, Niewiarowski S, Franecki G. Turnover of ¹³¹I-fibrinogen in mercury chloride intoxicated dogs Thrombos. Diathes. haemorrh. 1967; 18: 268
• 9 Girolami A, Clifton E.E. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 165
• 10 Gross R, Nieth H, Mammen E. Blutungsbereitschaft und Gerinnungsstörungen bei Urämie. Klin. Wschr. 1958; 36: 107
• 11 Gurewich V, Thomas D.P. Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. J. Lab. clin. Med. 1965; 66: 604
• 12 Heinrich R.A, von der Heide E.C, Climie A.R. Cryofibrinogen formation and inhibition in heparinized plasma. Amer. J. Physiol. 1963; 204: 419
• 13 Hellem A.J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. Suppl. 1960; 22: 57
• 14 Jeljaszewicz J, Niewiarowski S, Poplawski A, Prokopowicz J, Worowski K. Intravascular coagulation and fibrinolysis by staphylocoagulase Comparison with thrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 13: 457
• 15 Kendall A.G, Lowenstein L, Morgen R.O. The haemorrhagic diathesis in renal disease. Canad. med. Ass. J. 1961; 85: 405
• 16 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J. exp. Med. 1962; 115: 1065
• 17 Lesley Bidstrup P. Toxicity of mercury and its compounds. Elsevier; Amsterdam: 1964
• 18 Lewis J.H, Zucker M.B, Ferguson J.H. Bleeding tendency in uremia. Blood 1965; 11: 1073
• 19 Lorand L, Dickenman R.C. Assay method for the “fibrin-stabilizing factor”. Soc. exp. Biol. (N.Y.) 1955; 89: 45
• 20 McLean J.R, Maxwell R.E, Hertler D. Fibrinogen and adenosine diphosphate induced aggregation of platelets. Nature (Lond.) 1964; 202: 605
• 21 Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia (Basel). 1964; 2: 99
• 22 Niewiarowski S, Stuart R.K, Thomas D.P. Activation of intravascular coagulation by collagen. Proc. Soc. exp. Biol. (N. Y.) 1966; 123: 196
• 23 Niewiarowski S, Zywicka H, Latatto Z. Coagulation disorders in thrombocythemia. A study of seven cases Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 114
• 24 Penick G.D, Dejanov I.I, Reddick R.L, Roberts H.R. Predisposition to intravascular coagulation. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 21: 543
• 25 Quick A.J. The physiology and pathology of haemostasis, Kimpton. London: 1951
• 26 Schultz F.H. Das Fibrinogen. VEB Georg Thieme; Leipzig: 1953
• 27 Todd M.E. Coagulation studies in patients with the nephrotic syndrome and the uremic state. XIth Congress of the International Society of Haematology. Abstracts of papers; Sydney: 1966: 239 August
• 28 Wall R.L. The use of serum protein electrophoresis in clinical medicine. A. M. A. Archives of Internal Medicine 1958; 102: 618
• 29 Wolfson M, Cohns C, Colvary E, Ichiba F. Studies in serum proteins. Amer. J. clin. Path. 1948; 18: 723
• 30 Worowski K, Niewiarowski S, Prokopowicz J. Fibrinolysis and fibrinogen breakdown products (antithrombin VI) in renal venous blood (RVB) in dog. Thrombos. Diathes. heamorrh. (Stuttg.) 1964; 12: 87